PFSA — Profusa, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1859807 ·
Last close
$1.06
Market Cap
$561.8K
52W High
$14.98
52W Low
$0.86
ADV30
589,752
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -4,006,000 | -3,456,000 | 862,000 | 375,000 | 29,060,000 |
| Dec 2025 | 0 | — | -3,570,000 | -8,567,000 | 3,775,000 | 1,778,000 | 30,433,000 |
| Sep 2025 | 0 | — | -21,709,000 | -22,192,000 | 4,250,000 | 3,009,000 | 38,210,000 |
| Jun 2025 | 0 | — | -967,084 | -8,196,876 | 1,962,416 | 0 | 23,142,121 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-18,287,000
Investing CF
$-863,000
Financing CF
$19,506,000
CapEx
$-5,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-79.51
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-164,237,000
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-34,970,084
Pretax Income TTM
$-42,409,490
Interest Exp TTM
$1,347,000
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -27,706,000 | -35,823,000 | 3,775,000 | 30,433,000 | — | -16,248,000 |
| Dec 2024 | 0 | -4,500,000 | -9,230,000 | 3,073,000 | 122,278,000 | — | -2,066,000 |
| Dec 2023 | 0 | -6,070,000 | -10,281,000 | 1,893,000 | 111,889,000 | — | -4,402,000 |
| Dec 2022 | 0 | -9,443,000 | -20,217,000 | 1,031,000 | 100,802,000 | — | -7,702,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RBOT | Vicarious Surgical Inc. | $472.8K | $0.07 | — |
| LGMK | LogicMark, Inc. | $460.6K | $0.51 | — |
| ODYY | Odyssey Health, Inc. | $727.0K | $0.01 | — |
| LYRA | Lyra Therapeutics, Inc. | $843.1K | $0.47 | — |
| EMED | Electromedical Technologies, Inc | $373.2K | $0.00 | — |
News headlines (Yahoo Finance, 1h cache)
Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs
2026-07-31 21:15 · Yahoo
Profusa Signs Term Sheet for Diagnostics Acquisition and Announces Leadership Changes
2026-07-27 14:38 · Yahoo
Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company
2026-07-27 10:00 · Yahoo
This Biotech Stock Crashed 28% Today After Announcing Second Reverse Share Split This Year
2026-07-02 16:48 · Yahoo
Profusa Announces 1-for-25 Reverse Stock Split
2026-07-02 15:00 · Yahoo
Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts
2026-06-24 12:00 · Yahoo
Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform
2026-06-12 12:00 · Yahoo
Profusa Issues Letter to Shareholders Encouraging Shareholders to Vote FOR All Proposals at June 23, 2026 Annual Meeting
2026-06-10 12:00 · Yahoo
Profusa Announces Listing Transfer to The Nasdaq Capital Market
2026-05-15 11:30 · Yahoo
Profusa Receives Favorable Nasdaq Listing Determination
2026-05-08 10:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.